Ahmed Al‐Jedai

1.7k total citations
106 papers, 950 citations indexed

About

Ahmed Al‐Jedai is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Ahmed Al‐Jedai has authored 106 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Geriatrics and Gerontology, 20 papers in Economics and Econometrics and 18 papers in Epidemiology. Recurrent topics in Ahmed Al‐Jedai's work include Pharmaceutical Practices and Patient Outcomes (20 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Pharmaceutical Economics and Policy (11 papers). Ahmed Al‐Jedai is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (20 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Pharmaceutical Economics and Policy (11 papers). Ahmed Al‐Jedai collaborates with scholars based in Saudi Arabia, United States and Canada. Ahmed Al‐Jedai's co-authors include Fowad Khurshid, Ahmed Y. Mayet, Hajer Almudaiheem, Hisham A. Badreldin, Abdulrazaq S. Al‐Jazairi, Aws Alshamsan, Sara Alosaimy, Khalid Eljaaly, Mushira A. Enani and Ronak G. Gandhi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Transplantation.

In The Last Decade

Ahmed Al‐Jedai

88 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed Al‐Jedai Saudi Arabia 20 271 157 120 113 111 106 950
Samuel Limat France 20 247 0.9× 178 1.1× 91 0.8× 61 0.5× 75 0.7× 91 1.3k
Cristiano Soares de Moura Canada 17 238 0.9× 104 0.7× 67 0.6× 50 0.4× 128 1.2× 59 999
Obinna Ikechukwu Ekwunife Nigeria 17 128 0.5× 180 1.1× 95 0.8× 136 1.2× 137 1.2× 61 787
Vincent D. Marshall United States 18 91 0.3× 121 0.8× 57 0.5× 46 0.4× 107 1.0× 62 802
Thomas K. Hazlet United States 10 165 0.6× 438 2.8× 171 1.4× 49 0.4× 78 0.7× 19 985
Ana Ortega Spain 19 114 0.4× 421 2.7× 163 1.4× 419 3.7× 50 0.5× 76 1.4k
Mohamed Abdel-Latif Egypt 24 115 0.4× 64 0.4× 37 0.3× 54 0.5× 35 0.3× 76 1.9k
Rongsheng Zhao China 12 136 0.5× 51 0.3× 33 0.3× 167 1.5× 87 0.8× 67 756
Virginie Nerich France 20 110 0.4× 221 1.4× 208 1.7× 50 0.4× 93 0.8× 83 1.2k
Michael J. Malloy Australia 19 111 0.4× 656 4.2× 82 0.7× 42 0.4× 157 1.4× 55 1.3k

Countries citing papers authored by Ahmed Al‐Jedai

Since Specialization
Citations

This map shows the geographic impact of Ahmed Al‐Jedai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Al‐Jedai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Al‐Jedai more than expected).

Fields of papers citing papers by Ahmed Al‐Jedai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed Al‐Jedai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Al‐Jedai. The network helps show where Ahmed Al‐Jedai may publish in the future.

Co-authorship network of co-authors of Ahmed Al‐Jedai

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed Al‐Jedai. A scholar is included among the top collaborators of Ahmed Al‐Jedai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed Al‐Jedai. Ahmed Al‐Jedai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Abaalkhail, Faisal, Faisal M. Sanai, Khalid Alswat, et al.. (2025). Metabolic dysfunction-associated steatotic liver disease management in Saudi Arabia: A modified Delphi-based adaptation of international standards. Saudi Journal of Gastroenterology. 32(2). 104–120. 1 indexed citations
3.
Al‐Jedai, Ahmed, et al.. (2025). Saudi Consensus Report on Chronic Kidney Disease Management: Integrating the Latest Evidence and Clinical Practice Guidelines. International Journal of Clinical Medicine. 16(1). 54–88.
5.
Fasseeh, Ahmad Nader, et al.. (2025). Rare disease challenges and potential actions in the Middle East. International Journal for Equity in Health. 24(1). 56–56. 1 indexed citations
6.
7.
Alluhidan, Mohammed, et al.. (2024). Modeling the Clinical and Economic Burden of Therapeutic Inertia in People with Type 2 Diabetes in Saudi Arabia. Advances in Therapy. 41(11). 4140–4152. 1 indexed citations
8.
Fatani, Mohammad I., et al.. (2024). The Saudi consensus recommendations for the management of psoriatic arthritis (2023). Clinical Rheumatology. 43(3). 879–894. 3 indexed citations
9.
Saadah, Omar I., Turki AlAmeel, Mohammed Hasosah, et al.. (2024). Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents. Saudi Journal of Gastroenterology. 31(3). 107–136. 2 indexed citations
10.
Almangour, Thamer A., Majed S. Nassar, Ziad A. Memish, et al.. (2024). Epidemiology of Reportable Bacterial Infectious Diseases in Saudi Arabia. Infectious Diseases and Therapy. 13(4). 667–684. 5 indexed citations
11.
Al‐Jedai, Ahmed, et al.. (2023). The impact of a restricted pregabalin prescription policy on drug utilization: An observational multicenter study. Saudi Pharmaceutical Journal. 31(12). 101851–101851. 2 indexed citations
12.
Almudaiheem, Hajer, Zohair Al Aseri, Fahad Alrabiah, et al.. (2023). Prevalence and epidemiological trends in mortality due to COVID-19 in Saudi Arabia. Public Health. 215. 31–38. 4 indexed citations
13.
Alluhidan, Mohammed, et al.. (2023). Budget impact of introducing oral semaglutide to the public healthcare benefit package in Saudi Arabia. Journal of Medical Economics. 26(1). 1455–1468.
14.
Azzam, Nahla, Abdulelah Almutairdi, Hajer Almudaiheem, et al.. (2023). Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy. Saudi Journal of Gastroenterology. 1 indexed citations
16.
Alhasan, Khalid, Fadi Aljamaan, Mohamad‐Hani Temsah, et al.. (2021). COVID-19 Delta Variant: Perceptions, Worries, and Vaccine-Booster Acceptability among Healthcare Workers. Healthcare. 9(11). 1566–1566. 49 indexed citations
17.
Korayem, Ghazwa B., Hisham A. Badreldin, Khalid Eljaaly, et al.. (2021). Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacy. Saudi Pharmaceutical Journal. 29(11). 1343–1347. 21 indexed citations
18.
Badreldin, Hisham A., Sara Alosaimy, & Ahmed Al‐Jedai. (2020). Clinical pharmacy practice in Saudi Arabia: Historical evolution and future perspective. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(5). 920–929. 27 indexed citations
19.
Khurshid, Fowad, et al.. (2012). Hospital pharmacy practice in Saudi Arabia: Dispensing and administration in the Riyadh region. Saudi Pharmaceutical Journal. 20(4). 307–315. 38 indexed citations
20.
Mudawi, Hatim, Ahmed Helmy, Yasser Kamel, et al.. (2009). Recurrence of hepatitis C virus genotype-4 infection following orthotopic liver transplantation: Natural history and predictors of outcome. Annals of Saudi Medicine. 29(2). 91–97. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026